178 related articles for article (PubMed ID: 37516686)
21. Association between metabolic syndrome and clinicopathological features of papillary thyroid cancer.
Song JL; Li LR; Yu XZ; Zhan L; Xu ZL; Li JJ; Sun SR; Chen C
Endocrine; 2022 Mar; 75(3):865-871. PubMed ID: 34826117
[TBL] [Abstract][Full Text] [Related]
22. Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer.
Lu Y; Moreira AL; Hatzoglou V; Stambuk HE; Gonen M; Mazaheri Y; Deasy JO; Shaha AR; Tuttle RM; Shukla-Dave A
Thyroid; 2015 Jun; 25(6):672-80. PubMed ID: 25809949
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.
Xiao R; Ni C; Cai Y; Zhou Y; Gong X; Xie K; You J
Endocrine; 2023 Jun; 80(3):619-629. PubMed ID: 36696026
[TBL] [Abstract][Full Text] [Related]
24. Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?
Danilovic DLS; Castroneves LA; Suemoto CK; Elias LO; Soares IC; Camargo RY; Correa FA; Hoff AO; Marui S
Thyroid; 2020 Jul; 30(7):1008-1016. PubMed ID: 32059626
[No Abstract] [Full Text] [Related]
25. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.
Chung YS; Lee JH; Lee YD
Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453
[TBL] [Abstract][Full Text] [Related]
26. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
27. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
28. Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma.
Siraj AK; Parvathareddy SK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():777345. PubMed ID: 35355557
[TBL] [Abstract][Full Text] [Related]
29. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
Song RY; Kim HS; Kang KH
World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
[TBL] [Abstract][Full Text] [Related]
30. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
32. Annual Average Changes in Adult Obesity as a Risk Factor for Papillary Thyroid Cancer: A Large-Scale Case-Control Study.
Hwang Y; Lee KE; Park YJ; Kim SJ; Kwon H; Park DJ; Cho B; Choi HC; Kang D; Park SK
Medicine (Baltimore); 2016 Mar; 95(9):e2893. PubMed ID: 26945379
[TBL] [Abstract][Full Text] [Related]
33. Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.
Economides A; Giannakou K; Mamais I; Economides PA; Papageorgis P
Front Endocrinol (Lausanne); 2021; 12():692879. PubMed ID: 34276564
[TBL] [Abstract][Full Text] [Related]
34. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
35. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of the influence of body mass index on the clinicopathologic progression of papillary thyroid carcinoma.
Cui N; Sun Q; Chen L
Medicine (Baltimore); 2021 Aug; 100(32):e26882. PubMed ID: 34397906
[TBL] [Abstract][Full Text] [Related]
37. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
38. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
39. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma.
Jin BJ; Kim MK; Ji YB; Song CM; Park JH; Tae K
Oral Oncol; 2015 Aug; 51(8):759-63. PubMed ID: 26093388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]